Isoniazid Tablet Shortage
Last Updated: July 1, 2025
Status: Discontinued
To Be Discontinued:
- Isoniazid, Tablet, 300 mg (Genus Lifesciences)
- Tablet, 100 mg (Teva Pharmaceuticals USA, Inc.)
- Tablet, 300 mg (Teva Pharmaceuticals USA, Inc.)
Isoniazid, Tablet, 300 mg (Genus Lifesciences)
NDC Code: 64950-217-03Status: To Be Discontinued
Date of update: July 1, 2025
Update type: New
Related Information: Product expected to be available until August 2025.
Therapeutic category: Anti-Infective
Date discontinued: July 1, 2025
Initial posting date: July 1, 2025
Contact info: 610-782-9780
Isoniazid, Tablet, 300 mg (Genus Lifesciences)
NDC Code: 64950-217-10Status: To Be Discontinued
Date of update: July 1, 2025
Update type: New
Related Information: Product expected to be available until August 2025.
Therapeutic category: Anti-Infective
Date discontinued: July 1, 2025
Initial posting date: July 1, 2025
Contact info: 610-782-9780
Tablet, 100 mg (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0555-0066-02Status: To Be Discontinued
Date of update: November 21, 2024
Update type: New
Related Information: Product available through 12/03/2024
Therapeutic category: Anti-Infective
Date discontinued: November 21, 2024
Initial posting date: November 21, 2024
Contact info: 800-545-8800
Tablet, 300 mg (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0555-0071-01Status: To Be Discontinued
Date of update: November 21, 2024
Update type: New
Related Information: Product available through 12/03/2024
Therapeutic category: Anti-Infective
Date discontinued: November 21, 2024
Initial posting date: November 21, 2024
Contact info: 800-545-8800
Tablet, 300 mg (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0555-0071-02Status: To Be Discontinued
Date of update: November 21, 2024
Update type: New
Related Information: Product available through 12/03/2024
Therapeutic category: Anti-Infective
Date discontinued: November 21, 2024
Initial posting date: November 21, 2024
Contact info: 800-545-8800
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.